959581-75-0 Usage
Description
BOC-(TRANS)-4-(2-THIENYL)-PYRROLIDINE-3-CARBOXYLIC ACID is a chemical compound with potential pharmacological properties. It is a derivative of pyrrolidine and contains a carboxylic acid functional group, as well as a thienyl group. The BOC, or tert-butoxycarbonyl, is a protecting group often used in organic synthesis to protect amines and other reactive functional groups.
Uses
Used in Pharmaceutical Industry:
BOC-(TRANS)-4-(2-THIENYL)-PYRROLIDINE-3-CARBOXYLIC ACID is used as a building block for the development of new pharmaceuticals due to its unique chemical structure and potential pharmacological properties.
Used in Agrochemical Industry:
BOC-(TRANS)-4-(2-THIENYL)-PYRROLIDINE-3-CARBOXYLIC ACID is used as a precursor in the synthesis of agrochemicals, contributing to the development of new pesticides or other agricultural products.
Used in Organic Synthesis:
BOC-(TRANS)-4-(2-THIENYL)-PYRROLIDINE-3-CARBOXYLIC ACID is used as a protected amine intermediate in organic synthesis, where the BOC group can be selectively removed to reveal the amine functionality for further reactions.
Further research and testing are needed to fully understand the properties and potential applications of BOC-(TRANS)-4-(2-THIENYL)-PYRROLIDINE-3-CARBOXYLIC ACID.
Check Digit Verification of cas no
The CAS Registry Mumber 959581-75-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,5,8 and 1 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 959581-75:
(8*9)+(7*5)+(6*9)+(5*5)+(4*8)+(3*1)+(2*7)+(1*5)=240
240 % 10 = 0
So 959581-75-0 is a valid CAS Registry Number.
959581-75-0Relevant articles and documents
HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6
-
Paragraph 00392; 00396, (2021/09/04)
The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.